Tariffs have again become the center of global investing conversation, and they are biting deeper this time, with the U.S.

Arvinas PROTAC protein degraders have some potential, with vepdegestrant as its late-stage, most promising asset, partnered ...

Nasdaq and Dow rise as analysts upgrade Microsoft on AI, highlight Tesla challenges with tax credits, and Caterpillar ...